Aberrant hypomethylation of the cancer–testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia

Author： Ortmann Christina  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.87, Iss.10, 2008-10, pp. : 809-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer‐testis antigens PRAME and NY‐ESO‐1 correlate with tumour grade and poor prognosis in myxoid liposarcoma

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 3, 2015-06 ,pp. : 144-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

PRAME/EZH2-Mediated Regulation of TRAIL: A New Target for Cancer Therapy

By  

Current Molecular Medicine, Vol. 13, Iss. 2, 2012-12 ,pp. : 296-304

Bentham Science Publishers

Access to resources Recommend Favorite

Limited expression of cancer-testis antigens in renal cell carcinoma patients

By Soga  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 326-330

Spandidos Publications

Access to resources Recommend Favorite

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

By Greiner J.   Ringhoffer M.   Taniguchi M.   Schmitt A.   Kirchner D.   Krahn G.   Heilmann V.   Gschwend J.   Bergmann L.   Dohner H.   Schmitt M.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 1029-1035

Elsevier

Access to resources Recommend Favorite

The expression of LMO2 protein in acute B-cell and myeloid leukemia

By Cobanoglu Umit   Sonmez Mehmet   Ozbas Hasan Mucahit   Erkut Nergis   Can Gamze  

Hematology, Vol. 15, Iss. 3, 2010-06 ,pp. : 132-134

Maney Publishing

Access to resources Recommend Favorite